Skip to main content
ARXS logo

ARXS · Arxis, Inc.

Track ARXS — free
$54.05 +0.64 (+1.20%)
Market Cap
$23.00B
Shares
430.72M
Volume · Nov 18 490.92K Avg daily vol (3M) 894K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$53.41 Open$52.43 Day$52.37–54.16 Available close range$34.05–59.99 Avg vol 30d869K Short int6.3M · 1.5% of shares · 6.7d Short vol58% Last earningsOct 29, 2026 DataApr 2026–Nov 2026 Filing10-Q · Oct 29

The closing range uses available history since Apr 16, 2026; less than a full year is stored.

Up next

Jan 14, 2027 Est · unconfirmed · in 8 wks

Latest documents

2026
Oct 29
Earnings call
Revenue rises 36% as guidance increases

ARCSIS reported Q3 revenue of $564 million, up 36%, and raised full-year revenue guidance to $2.05 to $2.07 billion. FY2027 guidance calls for revenue of $2.4 to $2.5 billion and adjusted EBITDA of $1.01 to $1.06 billion.

4 source passages
Good morning, and welcome to the ARCSIS Third Quarter 2026 Results Conference Call. Q3 revenue was $564 million, an increase of 36% year-over-year, consisting of 29% organic growth and a 7% contribution from acquisition. We now expect revenue of $2.05 to $2.07 billion, an increase of $90 million at the midpoint, compared to our prior guidance. For FY2027, we expect a revenue of $2.4 to $2.5 billion, representing organic growth of 10% to 15%, and adjusted EBITDA of $1.01 to $1.06 billion, with an adjusted EBITDA margin of 42.1 to 42.4%. Open the document at this passage
Oct 29
Current report 8-K/A Events of Aug 17
Closes $770.0 Million Omnetics Merger Issuing 13,351,964 Class A Shares

Arxis closed its merger with Omnetics Connector Corporation on August 17, 2026, based on an agreed enterprise value of $770.0 million, subject to customary closing adjustments. At closing, it issued 13,351,964 shares of Class A common stock to former Omnetics shareholders and funded $8.0 million of cash escrow accounts.

Read from the first part of this long document
3 source passages
disclosing that on August 17, 2026, the Company closed on the transactions contemplated by the Agreement and Plan of Merger The aggregate consideration for the Merger was based on an agreed enterprise value, which was $770.0 million, subject to customary closing adjustments. At closing, the Company issued 13,351,964 shares of the Company’s Class A common stock, par value $0.01 per share (“Class A common stock”), to the former shareholders of Omnetics and funded $8.0 million of cash escrow accounts pursuant to the Merger Agreement. Open the document at this passage
Oct 29
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Revenue rises 36.0% to $564.0 million; net income $83.7 million

Arxis reported third-quarter 2026 revenue of $564.0 million, up 36.0% from $414.8 million, and net income of $83.7 million versus a net loss of $10.1 million in the 2025 period. Adjusted EBITDA was $255.9 million, or 45.4% of revenue, compared with $153.5 million, or 37.0%. Organic revenue rose 28.7%, and the April 2026 IPO raised net proceeds of $1,220.6 million, of which $946.0 million repaid the 2025 Term Loan.

Revenue $563.98M ▲ 36.0% Net income $83.71M Diluted EPS $0.20
Read from the MD&A section
6 source passages
We generated revenue of $564.0 million for the three months ended September 30, 2026, representing an increase of 36.0% compared to $414.8 million for the 2025 period. Net income for the three months ended September 30, 2026 was $83.7 million compared to a net loss of $10.1 million for the 2025 period. Adjusted EBITDA was $255.9 million, or 45.4% of revenue, for the three months ended September 30, 2026, compared to $153.5 million, or 37.0% of revenue, for the 2025 period. For the three months ended September 30, 2026 as compared to the 2025 period, organic revenue increased by $119.0 million, or 28.7%, which was driven by broad-based growth across all of our end markets, led by Industrial Technology, and supported by continued strength in Commercial Aerospace and Defense and Space. Net proceeds from the IPO were $1,220.6 million, after deducting underwriting discounts, commissions and offering costs. A portion of the net proceeds was used to repay $946.0 million of outstanding indebtedness under the Company’s 2025 Term Loan, with the remainder to be used for working capital and general corporate purposes. Open the document at this passage
Oct 28
Current report 8-K
Third-quarter revenue rises 36% to $564 million; 2027 guidance introduced

Arxis reported third-quarter 2026 revenue of $564 million, up 36%, and net income of $84 million versus a $(10) million loss a year earlier. Full-year 2026 revenue guidance was raised to $2,050 to $2,070 million, and 2027 revenue guidance of $2,400 to $2,500 million was introduced.

7 source passages
Third Quarter 2026 Highlights (all comparisons against the third quarter of 2025, unless otherwise noted): Revenue of $564 million, up 36% Net income of $84 million, compared to $(10) million Raising Full-Year 2026 Guidance (all comparisons against prior guidance midpoint, unless otherwise noted): Revenue range of $2,050 to $2,070 million, representing a 5% increase Introducing 2027 Guidance (all comparisons against 2026 guidance midpoint, unless otherwise noted): Revenue range of $2,400 to $2,500 million, representing 17% to 21% reported revenue growth and 10% to 15% organic growth Open the document at this passage
Oct 13
Registration statement S-1
Registration statement

Arxis, Inc. registered up to 13,351,964 Class A common shares for resale by selling stockholders; 4,422,677 shares are available, and the remainder becomes available by May 15, 2028. The company will receive no proceeds.

Read from the first part of this long document
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$1.92B
Trailing 12 months
Net income (TTM)
$221.78M
Trailing 12 months
Revenue growth YoY
+36.0%
Year over year
Operating margin
16.6%
Trailing 12 months
P / E (TTM)
103.7
Trailing earnings · reciprocal yield 1.0%
FCF yield
1.7%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
−$1.23B
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
1.5%
Latest settlement · 6.7 days to cover
View all 125 metrics

AI Brief

Q2 FY26 earnings call · Jul 30, 2026
Q2 FY26

TL;DR. Q2 revenue rose 25% to $501 million and adjusted EBITDA rose 38% to $211 million, and full-year 2026 revenue and adjusted EBITDA guidance were raised. A net loss of ($5) million was reported, with IPO share-based compensation offsetting operating improvement.

Bullish
  • + Q2 revenue up 25% to $501 million, including 21% organic growth
  • + Adjusted EBITDA up 38% to $211 million, with margin up 390 bps to 42.2%
  • + Full-year 2026 revenue guidance raised to $1,960 to $1,980 million, a 5% increase
  • + Full-year 2026 guidance raised: adjusted EBITDA range of $790 to $800 million
  • + Free cash flow of $127 million, up 261%
  • + Net leverage of 1.8x at quarter end, providing capacity for acquisitions
Bearish
  • − Net loss of ($5) million, with IPO share-based compensation offsetting operating improvement

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Buy Momentum Very Strong Sentiment Neutral Fundamentals Strong Quant / Vol Very High
Market backdrop VIX 24.6 · elevated Equity put/call 0.72
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 50-day avg +5%
above
RSI (14) 55
neutral
MACD trend Positive
52-week position 75%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Strong
1-month return +3%
trailing
6-month return +19%
trailing
Relative strength +22%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Accumulating
+13% holders QoQ · +44 funds added
Insider flow Distributing
Net -$2.1M over 90 days · 100% sells
Short interest Rising
1.45% of shares out · ▲ +9.6% MoM · 6.7 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
161 holders — 13F breadth
Squeeze score 63
elevated · 0–100
Fundamentals
Strong
Revenue growth +114%
Y/Y
Gross margin 47%
expanding
Balance sheet $2.4B
net debt
Quant / Vol
risk profile
Very High
Volatility 61%
annualized · 1-yr
Max drawdown −22%
past year
ATR 5.2%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Jul 30, 2026
full year 2026
Full year sales Maintained $1.96B – $1.98B
Jul 29, 2026 $1.96B – $1.98B changed to Jul 30, 2026 $1.96B – $1.98B
prior FY $1.59B midpoint +23.8% Y/Y
Adjusted EBITDA Non-GAAP Maintained $790M – $800M
Jul 29, 2026 $790M – $800M changed to Jul 30, 2026 $790M – $800M
Adjusted EBITDA margins Non-GAAP 40.4%
Organic growth Non-GAAP 20%
this year (2026)
Capital expenditures (CapEx) $60M
Previous outlook earlier release · from the 8-K filed Jul 29, 2026

Still-open targets the latest release did not restate under the same label.

Adjusted EBITDA margin · Full-Year 2026 40.4%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Buy
0 · 4 · 2
50 / 200-day cross
No cross Neutral
Price vs 50-day avg
+5% Bullish
RSI (14)
55 Neutral
MACD trend
Positive Bullish
52-week position
75% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Accumulating
+13% holders QoQ · +44 funds added
Insider flow Distributing
Net -$2.1M over 90 days · 100% sells
Short interest Rising
1.45% of shares out · ▲ +9.6% MoM · 6.7 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
161 holders — 13F breadth
Price context
position in its available closing range
Range low $34 Now $53 · 75% Range high $60
vs 50-day avg +5%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
GAAP → non-GAAP reconciliation
GAAP Net income (loss) before income taxes 119.73M
+4.91M Corporate costs
+17.89M Interest expense, net
+57.45M Depreciation and amortization
+5.59M Acquisition and integration costs
+0K Restructuring costs
+11.26M Transaction and other deal related expenses
+31.18M Share-based compensation expense
+12.84M Other non-recurring adjustments
= Segment Adjusted EBITDA 260.85M
Free Cash Flow non-GAAP $24.77M Three Months Ended March 31, 2026 filing —
GAAP → non-GAAP reconciliation
GAAP Net cash provided by operating activities 36.47M
-11.7M Capital expenditures
= Free Cash Flow 24.77M
Free Cash Flow Conversion non-GAAP 46.5% Three Months Ended March 31, 2026 filing —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Aerospace & Defense — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
ARXS
Arxis, Inc.
this stock
$23.00B — +114.1% — 1.5%
SPCX
Space Exploration Technologies Corp
$1.95T — — — 1.0%
GE
General Electric Co
$339.04B +6.5% +18.5% 37.8 1.2%
RTX
RTX Corp
$266.45B +7.7% +17.1% 32.1 1.0%
EADSF
Airbus SE
$170.45B -7.5% — — 0.1%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
161
% held
14.4%
Net QoQ
+1.7M sh
Top holder
T. Rowe Price Investment…
Held Float
View
Held by Funds
Fund positions
166
View
Short & Settlement
Short Interest Rising
Shares short
6.3M
Days to cover
6.7d
Change
+546.9K sh
View
Short Volume
Short vol %
58%
As of
Nov 18, 2026
Short Total
View
Fails to Deliver
FTD shares
641
Value
$35.2K
As of
Oct 30, 2026
View
Off-Exchange
Off-exchange %
45.4%
Week of
Oct 12, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$2.1M
Buyers / Sellers
0 / 2
Buyers Sellers
View
Financials
Financials
Revenue (FY)
$1.6B
Net income (FY)
$46.0M
View
Filings
SEC Filings
Latest
10-Q
Filed
Oct 29, 2026
This year
14

Arxis reported third-quarter 2026 revenue of $564.0 million, up 36.0% from $414.8 million, and net income of $83.7 million versus a net loss of $10.1 million in the 2025 period. Adjusted EBITDA was $255.9 million, or 45.4% of revenue, compared with $153.5 million, or 37.0%. Organic revenue rose 28.7%, and the April 2026 IPO raised net proceeds of $1,220.6 million, of which $946.0 million repaid the 2025 Term Loan.

View
Earnings & Events
Webcasts
Last webcast
Oct 29, 2026
View
Investor Relations
Latest news
Arxis Reports Third Quarter 2026…
Published
Oct 28, 2026
View

Performance

5D 20D 120D MTD YTD
ARXS -1.8% +3.2% +18.9% +5.1% —
SPY -3.9% -5.6% -3.5% -3.4% +7.1%
vs SPY +2.1% +8.8% +22.3% +8.5% —
Key facts CIK 2093536 CUSIP 04339D105 13F (30d) 159 filings 155 filers Visit website Investor relations